VPS11 and Leukoencephalopathy: In summary, our study identifies a homozygous mutation in VPS11 as causative in a novel leukoencephalopathy disorder associated with dysfunctional autophagy-lysosome trafficking pathway, and implicates VPS11 as a potential therapeutic drug target for this devastating infantile disease.